Mesoblast

$16.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.36 (+2.29%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Mesoblast and other stocks, options, and ETFs commission-free!

About MESO

Mesoblast Limited American Depositary Shares, also called Mesoblast, is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia. The listed name for MESO is Mesoblast Limited American Depositary Shares.

CEO
Silviu Itescu
Employees
102
Headquarters
Melbourne, Victoria (VIC)
Founded
2004
Market Cap
1.88B
Price-Earnings Ratio
Dividend Yield
Average Volume
647.70K
High Today
$16.11
Low Today
$15.05
Open Price
$15.05
Volume
372.67K
52 Week High
$21.28
52 Week Low
$3.12

Collections

MESO Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Feb 24, After Hours

You May Also Like